Results 101 to 110 of about 7,464 (222)

Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors.

open access: yesPLoS ONE, 2019
BackgroundWe aimed to describe the most frequently prescribed initial antiretroviral therapy (ART) regimens in recent years in HIV-positive persons in the Cohort of the Spanish HIV/AIDS Research Network (CoRIS) and to investigate factors associated with ...
Belén Alejos   +9 more
doaj   +1 more source

Análisis de la evolución de las causas de discontinuación del tratamiento antirretroviral en práctica real durante una década [PDF]

open access: yes, 2019
En la actualidad el virus de la inmunodeficiencia humana (VIH) sigue siendo un problema de salud a nivel mundial. Cuando estamos infectado por el VIH, este se replica en nuestro organismo pudiendo generar la enfermedad, síndrome de la inmunodeficiencia ...
Villegas Rodríguez, Ana
core  

Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study [PDF]

open access: yes, 2016
Effectiveness data of an unboosted atazanavir (ATV) with abacavir/lamivudine (ABC/3TC) switch strategy in clinical routine are scant.We evaluated treatment outcomes of ATV + ABC/3TC in pretreated subjects in the EuroSIDA cohort when started with ...
Beniowski, M   +20 more
core  

Pharmacokinetic interaction between single and multiple doses of darunavir, in combination with cobicistat or ritonavir, and single-dose dabigatran etexilate in healthy adults

open access: yesAAPS Open
Objective Darunavir (DRV) is a P-glycoprotein (P-gp) inhibitor. Dabigatran etexilate, prodrug of the anticoagulant dabigatran, is a P-gp probe substrate. This study evaluated the effect of single and multiple doses of DRV, coadministered with cobicistat (
Sandy Van Hemelryck   +5 more
doaj   +1 more source

Switch to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV aged 65 years or older: BICOLDER study – IMEA 057

open access: yesJournal of Infection and Public Health
Background: Polymedication and comorbidities are frequent in aging people with HIV (PWH) and often associated with elevated incidences of adverse events (AEs) and drug-drug interactions (DDIs).
Minh P. Lê   +12 more
doaj   +1 more source

Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake [PDF]

open access: yes, 2015
Amara, Alieu   +8 more
core   +1 more source

2016 Pipeline Report HIV and TB [PDF]

open access: yes, 2016
HIV and TB: Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in ...
Erica Lessem   +7 more
core  

Pulmonary hypertension in AIDS/HIV infection: a rare disease [PDF]

open access: yes, 2016
A Hipertensão pulmonar (HTP) é uma patologia rara mas que condiciona elevada morbilidade e mortalidade. É conhecida a sua associação com o Vírus da Imunodeficiência Humana (VIH), mas muitos dos mecanismos implicados na sua patogénese bem como o ...
Cardoso, C, Pacheco, P, Trigo, D
core  

Home - About - Disclaimer - Privacy